Eric McAllister, MD/PhD, on board as VP clinical affairs from Bristol-Myers Squibb, where he was most recently exec director of medical operations. Robert Baughman, PharmD/PhD, joins as director of preclinical development. He was previously group leader of R&D at Penederm and was formerly with Genentech.
You may also be interested in...
Abbott reported almost 28% revenue growth in the fourth quarter led by the exploding demand for COVID-19 tests and continued success of its FreeStyle Libre continuous glucose monitor.
While representing a smaller population, the ACTIVATE-T trial targeted patients seen as having greater unmet need.
As a freshman member on the US House Energy and Commerce Committee, former St. Jude Medical exec Rep. Angie Craig can help shape future health care, cybersecurity bills.